Inhibikase shareholders approve warrant issuance for private placement

Inhibikase Therapeutics, Inc.

Special Meeting held Aug 5, 2024; single proposal approved with 3,579,141 votes for.
Proposal: approve issuance of common stock purchase warrants under Nasdaq Listing Rule 5635(d).
Against: 84,029 votes; abstentions: 85,025; no broker non-votes.
Warrants relate to a private placement and a warrant inducement; no terms disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.